Arm’s ARM first-quarter results met guidance, with $1.06 billion in revenue and $0.35 in non-GAAP earnings per share.

Meta META closed the second quarter of fiscal 2025 with excellent financial results which included sales growing 22% to $47.5 ...

Jason Kephart: Active ETFs are at the top of model portfolio provider shopping lists: All the firms we surveyed expect to add ...

AbbVie's beat Wall Street's estimates for its top- and bottom-lines in the second quarter, boosted by sales of Skyrizi and Rinvoq. S&P Global said second-quarter profit rose due to "resilience in the ...

Major Wall Street banks have modestly lifted their oil-price forecasts for this year and next, but lingering uncertainty over U.S. tariffs and rising OPEC+ output continue to cloud the outlook. The ...

Oil futures fell after a three-day rally driven by a spate of U.S. trade deals ahead of Friday's tariff deadline and threats of sanctions against Russia and buyers of its oil. Natural gas futures fell ...

Automaker Stellantis said it appointed Scott Krugger to the newly created position of head of North America design, tasking him with steering the creative direction and design of the group's Chrysler, ...

The premium beer market in China would only be increasingly crowded as all major brewers have to resort to value growth. As an incumbent, Budweiser APAC would have to defend against a multitude of ...

ARM Holdings PLC Sponsored ADR (ARM) is currently at $145.21, down $18.11 or 11.09% --Would be lowest close since July 14, 2025, when it closed at $144.54 ...

--The copper market's long-term fundamentals remain "absolutely fantastic," fueled by strong demand for the metal due to the energy transition and a squeeze on supply, Anglo American Chief Executive ...

Watsco serves end markets with attractive long-term growth prospects driven by an undersupplied US housing stock, structurally higher repair and remodel spending, and favorable regulatory changes ...

Illumina has agreed to pay $9.8 million in a settlement with the Justice Department over allegations it sold federal agencies genomic sequencing systems with cybersecurity vulnerabilities.